Kendra Sweeney | Investor Relations |
Simba Gill | Chief Executive Officer |
Mark Bodmer | President of R&D, Chief Scientific Officer |
Jonathan Zung | Chief Development Officer |
Chris Howerton | Jefferies |
Gary Nachman | BMO Capital Markets |
Joseph Thome | Cowen |
Kristen Kluska | Cantor |
Gospel Asonye | Morgan Stanley |
00:04 Good morning and welcome to Evelo Biosciences Conference Call to discuss its Fourth Quarter and Full-Year 2021 Business Highlights. At this time, all participants are in a listen-only mode.
Following the formal remarks, we will open the call up for your questions. Please be advised that this call is being recorded at the company's request. 00:24 At this time, I'd like to turn the call over to Kendra Sweeney of Evelo.